The morbidity, mortality, and costs associated with Clostridium difficile infection

Jennie H Kwon; Margaret A Olsen; Erik R Dubberke

doi:10.1016/j.idc.2014.11.003

The morbidity, mortality, and costs associated with Clostridium difficile infection

Infect Dis Clin North Am. 2015 Mar;29(1):123-34. doi: 10.1016/j.idc.2014.11.003.

Authors

Jennie H Kwon¹, Margaret A Olsen², Erik R Dubberke³

Affiliations

¹ Division of Infectious Diseases, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St Louis, MO 63110, USA. Electronic address: jkwon@dom.wustl.edu.
² Divisions of Infectious Diseases and Public Health Sciences, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St Louis, MO 63110, USA.
³ Division of Infectious Diseases, Section of Transplant Infectious Diseases, Washington University School of Medicine, 660 South Euclid Avenue, Box 8051, St Louis, MO 63110, USA.

PMID: 25677706
DOI: 10.1016/j.idc.2014.11.003

Abstract

Clostridium difficile infection (CDI) is the most common cause of infectious health care-associated diarrhea and is a major burden to patients and the health care system. The incidence and severity of CDI remain at historically high levels. This article reviews the morbidity, mortality, and costs associated with CDI.

Keywords: Clostridium difficile; Costs; Morbidity; Mortality.

Publication types

Review

MeSH terms

Acute Disease / economics
Anti-Bacterial Agents / therapeutic use
Clostridioides difficile*
Clostridium Infections* / drug therapy
Clostridium Infections* / economics
Clostridium Infections* / microbiology
Clostridium Infections* / mortality
Cross Infection / economics
Cross Infection / microbiology
Cross Infection / mortality
Disease Outbreaks / economics
Hospital Costs*
Humans
Intestinal Diseases* / drug therapy
Intestinal Diseases* / economics
Intestinal Diseases* / microbiology
Intestinal Diseases* / mortality
Risk Factors

Substances

Anti-Bacterial Agents